• BigBear Pharma: Product Update Announcement for Baricitinib (BARUDX)

  Dear Customers, Partners, and Relevant Parties:Our company BigBear PharmaBaricitinib Tablets adopts pink coating powder for film coating. To further o···【Read More】

  Update: 13 Aug,2026Source: Haiou HealthViews: 216

• BigBear Pharma: Product Update Notice for Osimertinib(OYSIENDX)

  Dear Customers, Partners and Relevant Entities,The film‑coating of Osimertinib Tablets manufactured by BigBear Pharma Co., Limited uses light‑brown co···【Read More】

  Update: 11 Aug,2026Source: Haiou HealthViews: 214

• bigbear pharma: Product Update Announcement for Ivosidenib (AIVODX)

  Dear Customers, Partners, and Relevant Parties:Our companyBigBear Pharmauses blue coating powder for film coating of Ivosidenib tablets. Due to the re···【Read More】

  Update: 07 Aug,2026Source: Haiou HealthViews: 227

• bigbear pharma: Product Update Announcement for Apalutamide (APADX)

  Dear Customers, Partners and Relevant Parties:Our companyBigBear Pharma uses light brown coating powder for film coating of Apalutamide Tablets. To fu···【Read More】

  Update: 05 Aug,2026Source: Haiou HealthViews: 217

• FDA has approved Lytenava (bevacizumab-vikg) for neovascular age-related macular degeneration (nAMD)

  On July 24, 2026 local time, Outlook Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Lytenava (bevacizumab-···【Read More】

  Update: 03 Aug,2026Source: Haiou HealthViews: 194

• bigbear pharma:Product Update Announcement for Avatrombopag (AVATODX)

  Dear Customers, Partners and Relevant Entities:Our company, Bear Pharmaceutical Co., Ltd., uses light yellow coating powder for film coating of Avatro···【Read More】

  Update: 31 Jul,2026Source: Haiou HealthViews: 233

• bigbear pharma: Adagrasib (ADADX) Product Update Announcement

  Dear Customers, Partners and Relevant Parties:Our company, Daewoong Pharmaceutical Co., Ltd., uses white coating powder for film coating of Adagrasib.···【Read More】

  Update: 28 Jul,2026Source: Haiou HealthViews: 247

• Lao BigBear Pharmaceuticals obtains GMP certification for its traditional medicine processing plant, bringing its quality system to a new international stage

  BigBear Pharmaceuticals (Lao) has announced that its traditional medicine processing plant has successfully passed GMP (Good Manufacturing Practice) c···【Read More】

  Update: 13 Jul,2026Source: Haiou HealthViews: 275

• FDA approves Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease!

  Local time June 26, 2026, Viridian Therapeutics, Inc., a biotechnology company focused on discovering, developing, and commercializing potential best-···【Read More】

  Update: 01 Jul,2026Source: Haiou HealthViews: 268

• Sanofi’s Tzield Approved in the US as the First Disease-Modifying Therapy for Patients Recently Diagnosed with Stage 3 Type 1 Diabetes

  Paris, June 13, 2026. The US Food and Drug Administration (FDA) has granted accelerated approval to Tzield (teplizumab-mzwv) to delay the decline in e···【Read More】

  Update: 16 Jun,2026Source: Haiou HealthViews: 334

• FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease

  On 15 May 2026, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) and atezolizumab and hyaluronidase-tqjs (···【Read More】

  Update: 12 Jun,2026Source: Haiou HealthViews: 351

• FDA approves Lilly's EBGLYSS (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

  June 9, 2026 — Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved a new dosing regimen for EBGLYSS (lebriki···【Read More】

  Update: 10 Jun,2026Source: Haiou HealthViews: 339

• Treat quality as life! BigBear Pharma protects life and health with hardcore quality

  In the pharmaceutical industry, quality is not only the lifeline of an enterprise but also the most solemn commitment to every patient. Since its esta···【Read More】

  Update: 09 Jun,2026Source: Haiou HealthViews: 367

• Ivosidenib (AIVODX) manufactured by Big Bear Pharma has been approved in Laos

  Vientiane, Laos - January 3, 2024 - BigBearPharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer the···【Read More】

  Update: 08 Jun,2026Source: Haiou HealthViews: 325

• Trelagliptin (TEGLIDX) produced by BigBear Pharma has been approved in Laos

  Vientiane, Laos - January 3, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovative···【Read More】

  Update: 08 Jun,2026Source: Haiou HealthViews: 317